High-doses of vitamin C delivered in conjunction with IV chemotherapy may boost chemotherapy’s effectiveness and reduce side-effects in ovarian cancer treatment, according to a new study published this week. Researchers from the University of Kansas Medical Center found that patients who received vitamin C in conjunction with the conventional chemotherapy drugs paclitaxel or carboplatin reported fewer toxic effects. In the petri dish and in rats, vitamin C could enhance ability of chemotherapy to kill cancer cells, suggesting that it may improve chemotherapy’s effectiveness in people. While further study is needed to asses the long term benefits of vitamin C use, this is an encouraging step forward.
Read more about the study here.